InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 01/22/2019 7:41:50 AM

Tuesday, January 22, 2019 7:41:50 AM

Post# of 1570
News: $CYTK Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA

SOUTH SAN FRANCISCO, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it has received feedback from the U.S. Food and Drug Administration (FDA) that the Six Minute Walk Test (6MWT) is an acceptable primary efficacy endpoint for a poten...

Read the whole news https://marketwirenews.com/news-releases/cytokinetics-announces-receipt-of-fda-feedback-regarding-reldesemtiv-in-patients-with-sma-7414652.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News